JPMORGAN CHASE & CO - ARRAY BIOPHARMA INC ownership

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of ARRAY BIOPHARMA INC
ValueSharesWeighting
Q3 2017$2,261,000
+593.6%
1,256,000
+432.2%
0.00%
Q2 2017$326,000
-6.1%
236,000
-1.7%
0.00%
Q1 2017$347,000
-75.1%
240,000
-76.0%
0.00%
Q4 2016$1,396,000
-39.2%
1,000,000
-50.0%
0.00%
-100.0%
Q3 2016$2,295,000
+691.4%
2,000,000
+562.3%
0.00%
Q4 2015$290,000
-55.7%
302,000
-42.0%
0.00%
Q1 2015$654,000
-86.6%
521,000
-90.0%
0.00%
-100.0%
Q4 2014$4,881,000
+125.0%
5,224,000
+113.1%
0.00%0.0%
Q3 2014$2,169,000
-29.0%
2,451,000
-20.1%
0.00%0.0%
Q2 2014$3,057,000
+421.7%
3,069,000
+439.4%
0.00%
Q1 2014$586,000
+713.9%
569,000
+724.6%
0.00%
Q4 2013$72,000
-94.7%
69,000
-94.1%
0.00%
Q3 2013$1,347,000
-18.6%
1,173,000
-32.5%
0.00%
-100.0%
Q2 2013$1,654,0001,738,0000.00%
Other shareholders

There were no reported owners of ARRAY BIOPHARMA INC in Q4 2017.

NameSharesValueWeighting ↓
View complete list of ARRAY BIOPHARMA INC shareholders